Objective. Investigate determinants of receiving healthcare provider (HCP) recommendations for seasonal and H1N1 influenza vaccinations.
Introduction
In the United States (US), influenza (i.e., the flu) infections result in N200,000 hospitalizations and 24,000 deaths on average (Groshkopf et al., 2013) . Seasonal influenza vaccination is an important method for preventing the transmission of the influenza virus. Despite this recognition, gaps in vaccination coverage exist. Disparities in adult US influenza vaccination coverage exist between the elderly and nonelderly; populations at high-risk for influenza-related complications compared to otherwise; and, racial/ethnic minority groups compared to White, non-Hispanic groups (Lu et al., 2013; Centers for Disease Control and Prevention, 2011; Hebert et al., 2005; Fiscella, 2005; O'Malley & Forrest, 2006) . For example, influenza vaccination coverage for Non-Hispanic Whites is approximately 10 percentage-points higher than Non-Hispanic Black and Hispanic adults (Lu et al., 2013; O'Malley & Forrest, 2006) . And, White Medicare beneficiaries have a 1.52 higher odds of receiving an influenza vaccine in the past year than Black beneficiaries (O'Malley & Forrest, 2006) .
Receipt of a physician recommendation for an influenza vaccination has been studied based on patient (Armstrong et al., 2001; Hemingway & Poehling, 2004; Lyn-Cook et al., 2007; Ding et al., 2011; Nichol et al., 1992; Gnanasekaran et al., 2006; Fiebach & Viscoli, 1991; Pandolfi et al., 2012; Poehling et al., 2001; Mirza et al., 2008; Santibanez et al., 2010) or physician (Dominguez & Daum, 2005; Nichol & Zimmerman, 2001; Jessop et al., 2013; Levy et al., 2009 ) self-reports. These studies find a strong association between physician recommendation and the likelihood of obtaining an influenza vaccination for various patient groups. However, these studies predominantly focus on groups at high-risk for influenza-related complications (i.e., asthmatics, elderly adults) and racial/minority groups that have relatively low flu vaccine uptake. Therefore, there is limited generalizability to the general population.
Other studies demonstrate disparities in influenza vaccination rates for racial or ethnic minorities and those with lower socio-economic status (Takayama et al., 2012; Gu & Sood, 2011; Singleton et al., 2005; Annunziata et al., 2012) . However, it is not known the extent to which these patient groups received flu vaccine recommendations from their provider. Examining the patient populations likely to report a physician recommendation can influence policy initiatives with the goal of reducing disparities in vaccination rates. Similar work related to factors associated with recommendations for human papillomavirus (HPV) vaccines were recently assessed from patient (Ylitalo et al., 2013) and provider (Vadaparampil et al., 2014) perspectives. These studies find disparities in HPV vaccine recommendations among racial/ethnic groups.
The first objective of this study is to investigate the association between healthcare provider recommendations for influenza vaccinations and patient demographic, socioeconomic, and health access characteristics from a US population. The second objective is to determine whether Advisory Committee on Immunization Practices (ACIP) priority groups experienced flu vaccine recommendations from their healthcare provider at higher rates than non-ACIP priority groups.
Methods

Data source
Data came from the public-use National 2009 H1N1 Flu Survey (NHFS) by the Centers of Disease Control and Prevention (Department of Health & Human Servces (DHHS), 2012) and was reviewed by the National Center for Health Statistics Disclosure Review Board to protect participant privacy and data confidentiality. Households were identified from all 50 US states and the District of Columbia where both H1N1 and seasonal influenza vaccination coverage rates were evaluated, at national and state levels, for persons age ≥ 6 months. NHFS household interviews were conducted from October 2009 through June 2010. Interviews consisted of survey-respondent history of chronic conditions and respiratory illness; H1N1 and seasonal flu vaccination history; demographics and socioeconomic information; household characteristics; and, for adults, questions about knowledge, attitudes, and practices related to 2009 H1N1 and seasonal influenza. The reported Council of American Survey Research Organizations response rate range was 33.4% for landline telephones and 26.1% for cell phones (Department of Health & Human Servces (DHHS), 2012).
The NHFS is well suited to answer our research question because it is nationally representative, provides rates of reporting healthcare provider recommendations, and has rich information of respondent characteristics such as demographics, health care use, health status and beliefs about influenza vaccinations (Department of Health & Human Servces (DHHS), 2012).
Study population
This study focused on adult survey-respondents age 18+ that were interviewed from January through Restricting data to adults that visited a doctor's office, hospital, or clinic ensures that our primary outcome captures patients experiencing face-to-face flu vaccine recommendations that were likely tailored to the individual patient. Finally, we focused on adults because important respondent characteristics were only captured from adults (i.e., chronic medical condition status, work status, and opinions about the seasonal and H1N1 influenza vaccine).
Primary outcome measure
The primary outcome was adults' self-report of a doctor or other health professional personal recommendation for the H1N1 or seasonal flu vaccination since August 2009. Posted signs, newsletters, pamphlets, or television and radio ads were not considered a recommendation. Survey-respondents were given the following choices of HCP recommendations: (1) H1N1 flu vaccination; (2) seasonal flu vaccination; (3) both vaccinations; (4) neither vaccination; (5) don't know; and, (6) refused. Respondents reporting don't know and refused were grouped with neither vaccination response to create a four choice framework. These respondents were less than 5% of the total respondents grouped into neither vaccination recommendation. For our primary outcome, respondents indicating they received a recommendation for H1N1 flu vaccination only, seasonal flu vaccination only, or both vaccinations were grouped together and defined as a dichotomous variable.
Explanatory variables
Prior studies have limited information on predictors of healthcare provider recommendations for influenza vaccines. Therefore, similar to work on recommendations for human papillomavirus vaccinations (Ylitalo et al., 2013) , we utilize previously studied determinants of influenza vaccination to inform the variables in the adjusted models. This allows for a comprehensive comparison of differences in recommendation rates versus vaccination rates. For example, demographic characteristics such as males and non-White race are significantly associated with a lower likelihood of influenza vaccinations compared to females and White race groups, respectively. Further, compared to younger adults, older adults experience higher rates of influenza vaccinations (Takayama et al., 2012; Gu & Sood, 2011; Singleton et al., 2005; Annunziata et al., 2012; Centers for Disease Control and Prevention, 2009a; Centers for Disease Control and Prevention, 2009b) . Similar to prior work, we also adjust for marital status, number of children, number of household adults, Metropolitan Statistical Area, and Census region of residence Gu & Sood, 2011; Straits-Troster et al., 2006; Schneider et al., 2001; Lu et al., 2011; Mullahy, 1999; Egede & Zheng, 2003) . Interview date was included in our multivariate analysis to adjust for any time varying events that could affect the primary outcome.
Socioeconomic characteristics such as adults with higher education, higher incomes, employment status, and home ownership status are more likely to receive an influenza vaccination (Takayama et al., 2012; Gu & Sood, 2011; Singleton et al., 2005; Annunziata et al., 2012; Nagata et al., 2011) . Adults with health characteristics such as the presence of a chronic medical condition and poor health status are less likely to receive an influenza vaccination (Straits-Troster et al., 2006; Lu et al., 2011) . We include similar variables in our multivariate analysis.
For this time period, the ACIP defined priority patient groups in the case of vaccination shortages or limitations. The NHFS captures these priority groups as healthcare workers, adults with chronic medical conditions, and adults 50 years or older (Department of Health & Human Servces (DHHS), 2012). These groups receive priority during vaccine shortages because, for example, chronically ill adults (i.e., asthmatics, diabetics) have higher likelihoods of receiving an influenza infection when compared to non-chronically ill adults (Takayama et al., 2012; Annunziata et al., 2012; Department of Health & Human Servces (DHHS), 2012) .
We further adjust for access variables such as presence of health insurance and those who visit their doctor more frequently because these characteristics were associated with increased likelihood of influenza vaccinations (Takayama et al., 2012; Gu & Sood, 2011; Singleton et al., 2005; Annunziata et al., 2012) . Lastly, negative beliefs and opinions about vaccine effectiveness (e.g., vaccine side effects) create significant barriers to vaccination that contribute to disparities in vaccination rates (Fiscella, 2005; O'Malley & Forrest, 2006; Armstrong et al., 2001; Santibanez et al., 2010; Singleton et al., 2005) . Therefore, we examined whether HCP recommendations reach patients reporting similar barriers to vaccinations. In summary, these sample characteristics are grouped into demographic, socioeconomic, health, and access variables (Table 1A) and flu vaccine opinions (Table 1B) .
Statistical analysis
Sample weights provided by the NHFS were used to account for the complex survey sampling design. These weighted estimates produce nationally representative estimates of persons vaccinated or having Tables 1A and 1B , multivariate logistic regression models examined significant determinants of HCP recommendations. The 2009-2010 flu season was unique in providing both seasonal and H1N1 flu vaccinations, and there may be differences in HCP recommendations between these two vaccinations related to disease severity or infectiousness. Therefore, we conducted the following sensitivity analyses on the classification of HCP recommendations: defining the outcome as any seasonal (season flu vaccine only and both vaccinations) or any H1N1 (H1N1 flu vaccine only and both vaccinations) flu vaccine recommendations (Appendix A); relative risk ratios from a multinomial logit (MNL) model analyzing the polychotomous outcome of: no recommendation, receipt of H1N1 recommendation only, receipt of seasonal vaccination only, and receipt of both seasonal and H1N1 recommendations (Appendix B). To generalize our study to the prior literature, we estimated marginal effects where the primary outcome was HCP recommendation and compared them to marginal effects where the primary outcome was flu vaccinations (Appendix C). All analyses were conducted with Stata 11 (Stata Corp, College Station, TX).
Results
Unadjusted analyses of sample characteristics
Unadjusted analysis of the study population revealed older age was positively associated with receiving HCP recommendations (Table 1A) Table 1B reports the opinions about vaccine effectiveness, risk of getting sick with the flu without the vaccine, and worry about getting sick from the vaccine. First, the majority of our study sample considered the seasonal and H1N1 influenza vaccine as somewhat and very effective. These patient groups were more likely to have received a HCP recommendation. For example, 51.9% (95%CI: 50.0-53.9) of patients that considered the seasonal vaccine as very effective received a HCP recommendation compared to 26.9% (95%CI: 22.5-31.9) of patients that f This indicates whether the person has any of the following chronic medical conditions: asthma or another lung condition, diabetes, a heart condition, a kidney condition, sickle cell anemia or another anemia, a neurological or neuromuscular condition, a liver condition, or a weakened immune system caused by a chronic illness or by medicines taken for a chronic illness.
considered the seasonal vaccine as not at all effective. Second, about two thirds of the study population thought that they had a "very low" or "somewhat low" risk of getting sick with flu without either vaccine. However, the perception of getting sick with the flu, without either vaccine, was positively associated with receiving a HCP recommendation. Lastly, the study population was not predominantly worried about getting sick from either the seasonal or H1N1 flu vaccine; where patients with high levels of worry were more likely to report having a HCP recommendation.
Adjusted analyses of HCP recommendations for flu vaccinations
The logistic regression model for the primary outcome of this study (Table 2) demonstrates that ACIP priority groups such as adults aged 55+ and those reporting a chronic medical condition were more likely to report a HCP recommendation compared to their non-ACIP counterparts. Compared to 18-34 year olds, adults 55-64 and 65+ were 48.3% (95%CI: 1.237-1.778, Table 2 ) and 73.8% (95%CI: 1.427-2.116, Table 2 ) more likely to receive a recommendation, respectively. Adults with a chronic medical condition were 58.0% (95%CI: 1.414-1.765, Table 2 ) more likely to report a recommendation versus adults with no chronic medical condition. And, healthcare workers, another ACIP priority group, were not significantly associated with a recommendation. Reestimating the model (with and without race/ethnicity) in Table 2 by only adjusting for significant variables in Tables 1A and 1B did not considerably alter the findings.
Patients with health insurance were more likely to receive a HCP recommendation compared to patients with no health insurance (OR: 1.448, 95%CI: 1.165-1.801, Table 2 ). Also, compared to adults visiting a doctor at least 4 times, patients visiting a doctor once were 28.7% less likely to receive a recommendation (OR: 0.713, 95%CI: 0.618-0.821, Table 2 ). Lastly, there were racial/ethnic differences in HCP recommendations; where Non-Hispanic Black only adults were more likely to receive a HCP recommendation when compared to Non-Hispanic White only adults (OR: 1.284, 95%CI: 1.064-1.549).
Sensitivity analyses of adjusted models
The sensitivity analysis of the primary outcome can be found in Appendices A-C. The results from these model specifications were similar to the Table 2 results with few exceptions. For example, the results for any H1N1 vaccine recommendation outcome suggest no differences in HCP recommendation rates between racial/minorities and NonHispanic, White adults (Model 2 -Appendix A). There were no significant correlations associated with H1N1 vaccine only recommendations and age, race/ethnicity, and frequency of doctor's visits (Model 1C -Appendix B). Combined, these results suggest that recipients of H1N1 flu vaccine recommendations were evenly distributed among age, race/ethnicity, and frequency of doctor's visit when compared to seasonal flu vaccine recommendations. The MNL model results (Appendix B) demonstrate that recommendation disparities in key variables (i.e., age, race/ethnicity, and chronic illness status) were driven by seasonal flu vaccine recommendations rather than H1N1 flu vaccine recommendations. For example, Table 2 demonstrates that adults age 65 + and Non-Hispanic Black groups were more likely to receive recommendations compared to adults age 18-34 years and Non-Hispanic Whites, respectively. From Model 1C -Appendix B, these disparities do not exist when the outcome is H1N1 vaccine only. A similar trend can be ascertained when comparing the MNL model results to any H1N1 flu vaccine (Model 2 -Appendix A), where receiving a recommendation for both seasonal and H1N1 flu vaccines does not contribute to disparities in recommendations for age and race/ethnicity groups.
Lastly, similar to previous research, a HCP recommendation was significantly associated with obtaining seasonal and H1N1 flu vaccinations (Model 2 -Appendix C). Furthermore, this analysis reveals patients with low levels of opinion about seasonal flu vaccine effectiveness were less likely to receive a recommendation and any vaccine when compared to patients with high levels of opinion about seasonal flu vaccine effectiveness (Models 1 and 2 -Appendix C). Patients with low risk perceptions of getting sick with seasonal flu without the vaccine experienced similar negative associations with recommendations and vaccinations.
Discussion
Previous research on healthcare provider recommendations for influenza vaccination considers its effect on vaccination uptake. By characterizing the patient groups reporting a HCP recommendation, our study provides two important findings about determinants of HCP recommendations for flu vaccines.
First, our study demonstrates that Non-Hispanic, Black adults (a racial/ ethnic group typically less likely to obtain a flu vaccine) (Lu et al., 2013; Centers for Disease Control and Prevention, 2011; Hebert et al., 2005; Fiscella, 2005) were more likely to receive a recommendation compared to Non-Hispanic, White adults (Table 2 ). These findings suggest that disparities in HCP recommendation rates by race/ethnicity are not a likely explanation for disparities in flu vaccination rates by race/ethnicity. This naturally raises the question: Why do Non-Hispanic Black adults have lower vaccination rates despite receiving higher rates of HCP recommendations? One potential reason is that Non-Hispanic Black adults might be less receptive to advice from healthcare providers. For example, this demographic group may be resistant to vaccinations (Hebert et al., 2005) or more concerned about being experimented upon by physicians without consent (Fiscella, 2005) . Another explanation might be that racial/ethnic minority groups experience healthcare discrimination that may influence interactions within the healthcare setting leading to low patient adherence (MacIntosh et al., 2013) . Finally, other differences between racial/ethnic minority groups and NonHispanic Whites such as socio-economic status and trust in modern health care might explain the disparities in vaccination rates (O'Malley & Forrest, 2006) . Future research should carefully evaluate the importance of each of the above explanations to identify potential interventions for improving vaccination rates among minority racial/ethnic groups.
Second, ACIP priority groups are more likely to receive recommendations compared to non-ACIP groups and recommendations can contribute, in large part, towards obtaining a flu vaccination. For example, from Models 1 and 2 -Appendix C, our sample population has a 33.1% increased probability of obtaining flu vaccination given a vaccine recommendation from their provider. Chronically ill adults have a 4.9% higher chance of obtaining a flu vaccine compared to non-chronically ill adults. Moreover, chronically ill adults have a 10.9% higher chance of receiving a recommendation for flu vaccines compared to non-chronically ill adults. Taken together, receiving flu vaccine recommendations from providers explains 73.6% (i.e., 33.1% times 10.9% and divided by 4.9%) of the difference in flu vaccination rates between chronically ill and non-chronically ill adults. The HealthyPeople 2020 influenza vaccination goals suggest that further research is needed to improve vaccination rates for all patient groups (HealthyPeople2020, 2013). This study demonstrates that certain patient groups did not experience flu vaccine recommendations from their provider during the 2009-2010 flu season. The National Vaccine Advisory Committee has recently outlined recommendations as a standard for providers (Bhatt et al., 2014; Fiore et al., 2009 ). This is a promising step towards ensuring that recommendations reach all patient groups. However, relevant recommendation policies should also consider how provider recommendations reach patients and how providers respond when patients voice resistance to vaccine recommendations (Opel et al., 2013) .
There are several limitations to this study. First, it is likely that some doctor's visits were to non-primary care physicians or healthcare providers who are less likely to recommend seasonal and H1N1 flu vaccination. Ideally, we would like to distinguish between visits to primary care physicians versus other providers but we did not have data to make this distinction. Second, just like several other papers in this literature, we use self-reports to measure receipt of provider recommendation. Our findings might be biased due to measurement error if respondents misreport receipt of provider recommendations due to recall bias or other reasons. However, it is challenging to improve measurement of provider recommendations, as it is not feasible to observe doctor-patient interactions for a large representative sample of the US population. Finally, our findings show that patients who support flu vaccinations are likely to report a recommendation. However, this is an association and it is unclear whether provider recommendations change beliefs about flu vaccinations or whether patients predisposed to certain beliefs seek provider recommendations. Longitudinal studies that examine whether providers know about their patient's opinions prior to recommendations can further assess temporal differences in recommendation rates. And, future work may wish to discern how the provider delivered the recommendation (i.e., whether the recommendation was a face-to-face verbal communication).
There are limited studies in describing patient characteristics associated with influenza vaccine provider recommendations. Despite this limitation, we use prior work on patient characteristics associated with influenza vaccinations to inform our model adjustments. The advantage of this approach is that it considers prior relationships in vaccination status. However, it is possible that these relationships may not be relevant to a provider recommendation, which we demonstrate in our study. Thus, it is important that future research explores the relative associations of similar patient characteristics with provider recommendations for influenza vaccines.
Further, unique to the 2009-2010 flu season, the distinction between seasonal and H1N1 flu vaccinations may not be fully understood by survey-respondents. However, our sensitivity analyses related to this distinction suggest generally robust results (Appendices A-B). And, it is possible that respondents reporting don't know and refused, as a response to whether they received a recommendation, couldn't differentiate between recommendations of vaccinations. We re-estimated our primary analysis by excluding these respondent groups. When compared to Table 2 , the findings did not significantly change (data available upon request). However, since the 2009-2010 flu season experienced the H1N1 flu pandemic, these findings may not generalize to other flu seasons. Although, these results are relevant to future influenza pandemics because policies related to ensuring influenza vaccination coverage will benefit from our study conclusions on HCP recommendations.
Conclusions
Healthcare provider recommendations for influenza vaccinations play an important role in improving vaccination rates, especially among ACIP priority groups. This study demonstrates that these priority groups were more likely to report healthcare provider recommendations for influenza vaccinations during the 2009-2010 flu season when compared to non-priority groups. Unlike similar studies in HPV vaccine recommendations, Non-Hispanic Blacks were more likely to receive recommendations compared to NonHispanic Whites.
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